then again, maybe the market doesn't expect too much sp appreciation upon listing on NASDAQ as before when DNDN was at $30-50.
if we list we are at $5.40 compared to DNDN at $14-15 considering they already for FDA and generating revenue. there does not appear to be any more upside at least in the short term OR unless DNDN sp goes up higher on higher revenue/profit
JIMO
files registration statement for listing of ad, page-5
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |